Qingwei Chu

6.2k total citations · 4 hit papers
15 papers, 4.3k citations indexed

About

Qingwei Chu is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Qingwei Chu has authored 15 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Surgery and 3 papers in Physiology. Recurrent topics in Qingwei Chu's work include Metabolism, Diabetes, and Cancer (8 papers), Pancreatic function and diabetes (5 papers) and FOXO transcription factor regulation (4 papers). Qingwei Chu is often cited by papers focused on Metabolism, Diabetes, and Cancer (8 papers), Pancreatic function and diabetes (5 papers) and FOXO transcription factor regulation (4 papers). Qingwei Chu collaborates with scholars based in United States, France and Switzerland. Qingwei Chu's co-authors include Morris J. Birnbaum, Joanne L. Thorvaldsen, Han Cho, Klaus H. Kaestner, Fei Feng, Marisa S. Bartolomei, James Mu, Gerald I. Shulman, Jason K. Kim and E. Bryan Crenshaw and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Qingwei Chu

15 papers receiving 4.3k citations

Hit Papers

Insulin Resistance and a Diabetes Mellitus-Like Syndrome ... 2001 2026 2009 2017 2001 2001 2013 2018 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingwei Chu United States 13 3.1k 1.1k 1.0k 775 570 15 4.3k
Sophie Vaulont France 29 2.7k 0.9× 1.5k 1.3× 1.1k 1.1× 541 0.7× 450 0.8× 56 4.1k
Jinny S. Wong United States 27 2.0k 0.7× 1.2k 1.0× 671 0.7× 789 1.0× 676 1.2× 31 4.1k
Kouichi Inukai Japan 41 3.1k 1.0× 1.2k 1.1× 1.2k 1.1× 974 1.3× 995 1.7× 99 5.6k
Motonobu Anai Japan 44 3.0k 1.0× 1.4k 1.2× 1.2k 1.2× 1.3k 1.6× 891 1.6× 77 5.2k
S.R. Murthy Madiraju Canada 27 1.6k 0.5× 1.3k 1.1× 758 0.7× 683 0.9× 342 0.6× 51 3.1k
Sung Hee Um South Korea 26 3.2k 1.0× 635 0.6× 1.1k 1.1× 280 0.4× 640 1.1× 56 4.7k
Brice Emanuelli Denmark 20 2.6k 0.8× 671 0.6× 1.8k 1.8× 746 1.0× 1.3k 2.2× 36 5.0k
Yukari Kitamura Japan 20 3.8k 1.2× 1.7k 1.5× 1.5k 1.5× 669 0.9× 628 1.1× 30 5.5k
Trey Coleman United States 30 2.0k 0.7× 761 0.7× 1.6k 1.5× 552 0.7× 955 1.7× 42 4.0k
Raymond E. Soccio United States 21 1.9k 0.6× 734 0.7× 517 0.5× 339 0.4× 375 0.7× 26 3.0k

Countries citing papers authored by Qingwei Chu

Since Specialization
Citations

This map shows the geographic impact of Qingwei Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingwei Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingwei Chu more than expected).

Fields of papers citing papers by Qingwei Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingwei Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingwei Chu. The network helps show where Qingwei Chu may publish in the future.

Co-authorship network of co-authors of Qingwei Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingwei Chu. A scholar is included among the top collaborators of Qingwei Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingwei Chu. Qingwei Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bowman, Caitlyn E., Michael D. Neinast, Cholsoon Jang, et al.. (2025). Off-target depletion of plasma tryptophan by allosteric inhibitors of BCKDK. Molecular Metabolism. 97. 102165–102165. 1 indexed citations
2.
TeSlaa, Tara, Won Dong Lee, Qingwei Chu, et al.. (2024). Quantification of nutrient fluxes during acute exercise in mice. Cell Metabolism. 36(12). 2560–2579.e5. 7 indexed citations
3.
Bornstein, Marc R., Michael D. Neinast, Xianfeng Zeng, et al.. (2023). Comprehensive quantification of metabolic flux during acute cold stress in mice. Cell Metabolism. 35(11). 2077–2092.e6. 33 indexed citations
4.
Chellappa, Karthikeyani, Melanie R. McReynolds, Wenyun Lu, et al.. (2022). NAD precursors cycle between host tissues and the gut microbiome. Cell Metabolism. 34(12). 1947–1959.e5. 73 indexed citations
5.
Mukherjee, Sarmistha, Caroline Perry, Qingwei Chu, et al.. (2021). SIRT3 is required for liver regeneration but not for the beneficial effect of nicotinamide riboside. JCI Insight. 6(7). 24 indexed citations
6.
Neinast, Michael D., Cholsoon Jang, Sheng Hui, et al.. (2018). Quantitative Analysis of the Whole-Body Metabolic Fate of Branched-Chain Amino Acids. Cell Metabolism. 29(2). 417–429.e4. 342 indexed citations breakdown →
7.
Titchenell, Paul M., William J. Quinn, Mingjian Lu, et al.. (2016). Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production. Cell Metabolism. 23(6). 1154–1166. 216 indexed citations
8.
Titchenell, Paul M., Qingwei Chu, Bobby R. Monks, & Morris J. Birnbaum. (2015). Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo. Nature Communications. 6(1). 7078–7078. 128 indexed citations
9.
Koren, Shlomit, Lisa M. DiPilato, Matthew J. Emmett, et al.. (2015). The role of mouse Akt2 in insulin-dependent suppression of adipocyte lipolysis in vivo. Diabetologia. 58(5). 1063–1070. 22 indexed citations
10.
Miller, Russell, Qingwei Chu, Jianxin Xie, et al.. (2013). Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature. 494(7436). 256–260. 662 indexed citations breakdown →
11.
Wan, Min, Karla F. Leavens, Roger W. Hunter, et al.. (2013). A Noncanonical, GSK3-Independent Pathway Controls Postprandial Hepatic Glycogen Deposition. Cell Metabolism. 18(1). 99–105. 65 indexed citations
12.
Lu, Mingjian, Min Wan, Karla F. Leavens, et al.. (2012). Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nature Medicine. 18(3). 388–395. 306 indexed citations
13.
Miller, Russell, Qingwei Chu, John Le Lay, et al.. (2011). Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling. Journal of Clinical Investigation. 121(6). 2518–2528. 142 indexed citations
14.
Cho, Han, James Mu, Jason K. Kim, et al.. (2001). Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ). Science. 292(5522). 1728–1731. 1512 indexed citations breakdown →
15.
Cho, Han, Joanne L. Thorvaldsen, Qingwei Chu, Fei Feng, & Morris J. Birnbaum. (2001). Akt1/PKBα Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice. Journal of Biological Chemistry. 276(42). 38349–38352. 795 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026